Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 July 2019 | Story Valentino Ndaba | Photo Barend Nagel
Dr Musawenkosi Saurombe and Innocensia Mangoato
Dr Musawenkosi Saurombe and Innocensia Mangoato: 2 of 200 Young South Africans honoured by the Mail & Guardian.

The one is Africa’s youngest PhD graduate. The other made waves with her research into cannabis as a cancer treatment. Dr Musawenkosi Saurombe and Innocensia Mangoato are both lecturers at the University of the Free State (UFS). Now they also share the title of 2019 Mail & Guardian 200 Young South Africans. Dr Saurombe is a Senior Lecturer in the Department of Industrial Psychology and Innocensia Mangoato is a lecturer in the Department of Pharmacology.

For the past 13 years the award has been a career launch pad for many leaders. These Kovsies are however already “on course to touch the world with their greatness”, in the words of the Mail & Guardian. 

In Dr Saurombe’s case, this honour comes after being named the 2018/19 Youth Leader of the Year by the Institute of People Management for being Africa’s youngest PhD graduate and contributing significantly to the talent management field. On the other hand, Mangoato earned the 2018 South African Women in Science Award for her research on using cannabis in cancer treatment
 
A mark of distinction

On 27 June 2019 Dr Saurombe’s name lit up the screen as the Education category winner at a gala dinner held in Sandton. Mangoato was recognised as one of the country’s brightest minds in the Science and Technology category.

Mastering science of excelling

Mangoato believes that the science of excelling is taught through living as an example. “The fact that a village girl can be recognised for conducting impactful research that will potentially result in new knowledge production in the area of drug development and using natural products should encourage more young people to achieve greatness regardless of their circumstances.”

The Pharmacology lecturer and researcher remains persistent in pursuit of her PhD and ground-breaking research in cancer-drug resistance. 

Youngest PhD graduate in Africa

At four years old, a young Dr Saurombe started school in Botswana. She was promoted past a few grades due to being more advanced than her peers. This led her to complete high school at 15 and enrol at North-West University as a first-year student the following year.

In 2017, she was celebrated across the continent as being the youngest PhD graduate at 23. “I registered for my PhD without knowing where I’d get the money to fund my studies,” said Dr Saurombe reflecting on how financial constraints encouraged her to complete her PhD in one-and-a-half years. 

Dr Saurombe joined the UFS earlier this year as a senior lecturer in Industrial Psychology and continues her research into the relationship between employer and employee focusing on talent value proposition.


News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept